If you could vote on Brexit now which option would you choose?
   

Valneva says European Commission to terminate purchase agreement for its VLA2001 COVID candidate


Valneva said on Monday it had received a notice of intent from the European Commission (EC) to terminate the advance purchase agreement for its VLA2001 COVID-19 candidate vaccine. 'The EC decision is regrettable especially as we continue to receive messages from Europeans who are looking for a more traditional vaccine solution,' CEO Thomas Lingelbach said. Valneva's vaccine relies on technology that has been used for decades, including in some shots against polio, influenza and hepatitis. Valneva signed a deal with the EC last November to supply up to 60 million doses of vaccine over two years, including 24.3 million doses in 2022.

Reuters - May 16, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/valneva-says-european-commission-terminate-purchase-agreement-its-vla2001-covid-2022-05-16/